Walleye Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.7M | Sell |
409,200
-31,900
| -7% | -$2.22M | 0.04% | 424 |
|
|
2025
Q4 | $29.3M | Buy |
441,100
+1,300
| +0.3% | +$84K | 0.04% | 458 |
|
|
2025
Q3 | $29.6M | Buy |
439,800
+56,900
| +15% | +$4.5M | 0.05% | 431 |
|
|
2025
Q2 | $33.4M | Buy |
382,900
+15,400
| +4% | +$1.21M | 0.06% | 342 |
|
|
2025
Q1 | $25.1M | Sell |
367,500
-82,600
| -18% | -$6.74M | 0.06% | 372 |
|
|
2024
Q4 | $35M | Buy |
450,100
+160,000
| +55% | +$11.8M | 0.07% | 287 |
|
|
2024
Q3 | $19.4M | Sell |
290,100
-18,000
| -6% | -$1.48M | 0.04% | 474 |
|
|
2024
Q2 | $34.9M | Buy |
308,100
+233,600
| +314% | +$29.5M | 0.08% | 251 |
|
|
2024
Q1 | $10.3M | Sell |
74,500
-89,200
| -54% | -$11.2M | 0.02% | 706 |
|
|
2023
Q4 | $20.3M | Buy |
163,700
+44,700
| +38% | +$4.57M | 0.04% | 433 |
|
|
2023
Q3 | $11.1M | Sell |
119,000
-3,000
| -2% | -$338K | 0.03% | 631 |
|
|
2023
Q2 | $15.7M | Sell |
122,000
-36,600
| -23% | -$4.43M | 0.05% | 381 |
|
|
2023
Q1 | $18.4M | Sell |
158,600
-62,200
| -28% | -$6.96M | 0.04% | 414 |
|
|
2022
Q4 | $25M | Buy |
220,800
+53,700
| +32% | +$5.9M | 0.07% | 296 |
|
|
2022
Q3 | $13.5M | Buy |
167,100
+27,600
| +20% | +$2.34M | 0.04% | 480 |
|
|
2022
Q2 | $10.4M | Buy |
139,500
+84,300
| +153% | +$7.69M | 0.03% | 585 |
|
|
2022
Q1 | $7.06M | Buy |
55,200
+2,400
| +5% | +$263K | 0.02% | 797 |
|
|
2021
Q4 | $7.09M | Sell |
52,800
-28,000
| -35% | -$4.02M | 0.02% | 783 |
|
|
2021
Q3 | $11M | Buy |
80,800
+61,200
| +312% | +$7.72M | 0.04% | 503 |
|
|
2021
Q2 | $2.09M | Sell |
19,600
-14,400
| -42% | -$1.38M | 0.01% | 1462 |
|
|
2021
Q1 | $3.06M | Sell |
34,000
-18,800
| -36% | -$1.76M | 0.01% | 999 |
|
|
2020
Q4 | $4.88M | Sell |
52,800
-9,200
| -15% | -$821K | 0.02% | 748 |
|
|
2020
Q3 | $6.39M | Sell |
62,000
-21,600
| -26% | -$2.26M | 0.03% | 459 |
|
|
2020
Q2 | $8.47M | Buy |
83,600
+66,800
| +398% | +$5.98M | 0.05% | 331 |
|
|
2020
Q1 | $1.13M | Sell |
16,800
-38,000
| -69% | -$2.36M | 0.01% | 1215 |
|
|
2019
Q4 | $3M | Buy |
54,800
+8,800
| +19% | +$417K | 0.02% | 908 |
|
|
2019
Q3 | $1.72M | Sell |
46,000
-26,000
| -36% | -$1.01M | 0.01% | 1168 |
|
|
2019
Q2 | $2.7M | Buy |
72,000
+10,400
| +17% | +$327K | 0.02% | 824 |
|
|
2019
Q1 | $1.83M | Buy |
61,600
+34,800
| +130% | +$1.22M | 0.01% | 1153 |
|
|
2018
Q4 | $803K | Sell |
26,800
-800
| -3% | -$25.4K | 0.01% | 1960 |
|
|
2018
Q3 | $987K | Sell |
27,600
-7,200
| -21% | -$223K | 0.01% | 2079 |
|
|
2018
Q2 | $826K | Sell |
34,800
-70,800
| -67% | -$1.5M | ﹤0.01% | 2306 |
|
|
2018
Q1 | $1.96M | Buy |
105,600
+104,400
| +8,700% | +$1.54M | 0.01% | 1219 |
|
|
2017
Q4 | $17 | Sell |
1,200
-136,800
| -99% | -$1.78M | ﹤0.01% | 4187 |
|
|
2017
Q3 | $1.69K | Buy |
138,000
+12,000
| +10% | +$212K | 0.01% | 1411 |
|
|
2017
Q2 | $2.31K | Buy |
126,000
+70,000
| +125% | +$1.29M | 0.01% | 1093 |
|
|
2017
Q1 | $1.19K | Buy |
56,000
+46,400
| +483% | +$906K | 0.01% | 1497 |
|
|
2016
Q4 | $143K | Buy |
+9,600
| New | +$170K | ﹤0.01% | 3021 |
|
Other funds holding DXCM
VCM
VPM
Walleye Trading's DXCM Position: Q1 2026 in Review
Walleye Trading reduced its DexCom (DXCM) stake by 63% in Q1 2026, selling an estimated $8.02M and leaving 68,250 shares worth $4.29M. The position accounts for 0.01% of the portfolio, ranked #1224.
Walleye Trading first reported a position in DXCM in Q4 2015 and has held it in 23 quarters since. The position peaked at $12.2M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Walleye Trading held 68,250 shares of DexCom worth $4.29M as of Q1 2026.
- Walleye Trading sold 115,151 DexCom shares in Q1 2026, an estimated $8.02M.
- DexCom made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #1224 holding.
- Walleye Trading first reported a position in DexCom in Q4 2015 and has held it in 23 quarters since.
- Walleye Trading's DexCom position peaked at $12.2M in Q4 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.